Bacteriophage Therapy for Orthopedic Implant-Associated Infections
Trial statusNot yet recruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18+
SponsorSecond Affiliated Hospital, School of Medicine, Zhejiang University
About this trial
A Prospective, Single-Center, Single-Arm Clinical Study with a Pre-Post Self-Controlled Design Evaluating the Efficacy and Safety of Bacteriophage Therapy for Refractory Orthopedic Implant-Associated Infections
Eligibility criteria
Qualifiers
Known allergy or hypersensitivity to bacteriophages or any components of the bacteriophage preparation;
Pregnant or breastfeeding women;
Participation in another interventional clinical trial within the study period;
Lack of feasible routes of administration other than intravenous injection;
Disqualifiers
Withdrawal of informed consent by the participant at any time during the study;
Occurrence of serious adverse events related to bacteriophage therapy that, in the investigator's judgment, necessitate discontinuation of treatment.
Trial design
Treatments tested in this trial
- bacteriophage preparation
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov